查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1874372

过敏免疫疗法：全球市场份额和排名、总收入和需求预测（2025-2031年）

Allergy Immunotherapy - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
出版日期: | 出版商: QYResearch | 英文 108 Pages | 商品交期: 2-3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

全球过敏免疫疗法市场预计在 2024 年达到 17.85 亿美元，预计到 2031 年将达到 28.05 亿美元，2025 年至 2031 年的复合年增长率为 7.0%。

本报告对近期关税调整和国际策略反制措施对过敏免疫疗法的跨境产业布局、资本配置模式、区域经济相互依存关係和供应链重组进行了全面评估。

过敏原免疫疗法（也称为减敏疗法或低敏性疗法）是一种针对某些类型过敏症的治疗方法。它对环境过敏、昆虫叮咬过敏和气喘有效。但其对食物过敏的疗效尚不明确，因此不建议使用。免疫疗法透过逐步增加过敏原的剂量，来改变免疫系统的反应。过敏原免疫疗法（AIT）的主要治疗目标包括减轻症状、减少症状药物的使用、改善过敏相关的生活品质。有充分的证据表明，AIT能够实现这些目标并改变疾病进程，许多患者在停止治疗后仍能持续获益多年。

全球过敏免疫疗法市场主要受过敏性疾病（尤其是过敏性鼻炎、气喘和食物过敏）盛行率上升的驱动，这些疾病影响着全球数亿人。人们对长期治疗方案的认识不断提高，以及免疫疗法在持续缓解症状方面的疗效，推动了其应用。此外，诊断技术的进步、舌下片等製剂的改进以及监管支持也促进了市场成长。对个人化医疗日益增长的需求以及向疾病修正治疗的转变，进一步推动了市场发展。

儘管过敏免疫疗法具有潜在的治疗益处，但市场仍面临许多挑战。较长的疗程（通常为3-5年）可能导致患者依从性差，且脱落率高。高昂的前期费用以及部分地区有限的健保覆盖范围，使得许多患者无法获得治疗。此外，特别是皮下免疫疗法，需要专门的医疗基础设施和训练有素的专业人员，这限制了其在资源匮乏地区的普及。安全性问题，包括全身性过敏反应的风险，也阻碍了该疗法的广泛应用，尤其是在儿童和老年人群中。这些障碍共同作用，减缓了市场渗透速度，并限制了治疗方法潜力。

本报告旨在对全球过敏免疫疗法市场进行全面分析，重点关注总销售量、收入、价格、市场份额和主要企业的排名，并按地区/国家、类型和应用对过敏免疫疗法进行分析。

本报告以销售（千）和收入（百万美元）为单位，对过敏免疫疗法市场规模、估算和预测进行了呈现，基准年为2024年，并涵盖了2020年至2031年的历史数据和预测数据。透过定量和定性分析，我们帮助读者制定过敏免疫疗法业务和成长策略，评估市场竞争，分析自身在当前市场中的地位，并做出明智的商业决策。

市场区隔

公司

  • ALK-Abello
  • Stallergenes Greer
  • Merck
  • Allergy Therapeutics
  • HAL
  • Holister Stier
  • Leti
  • WOLW Pharma

按类型分類的细分市场

  • 皮下免疫疗法
  • 舌下免疫疗法

应用领域

  • 过敏性鼻炎
  • 过敏性气喘
  • 其他的

按地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太地区
    • 中国
    • 日本
    • 韩国
    • 东南亚
    • 印度
    • 澳洲
    • 亚太其他地区
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 荷兰
    • 北欧国家
    • 其他欧洲
  • 拉丁美洲
    • 墨西哥
    • 巴西
    • 其他拉丁美洲
  • 中东和非洲
    • 土耳其
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 其他中东和非洲地区

The global market for Allergy Immunotherapy was estimated to be worth US$ 1785 million in 2024 and is forecast to a readjusted size of US$ 2805 million by 2031 with a CAGR of 7.0% during the forecast period 2025-2031.

This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Allergy Immunotherapy cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.

Allergen immunotherapy, also known as desensitization or hypo-sensitization, is a medical treatment for some types of allergies. It is useful for environmental allergies, allergies to insect bites, and asthma. Its benefit for food allergies is unclear and thus not recommended. Immunotherapy involves exposing people to larger and larger amounts of allergen in an attempt to change the immune system's response. The primary therapeutic goals of allergy immunotherapy (AIT) include reducing symptoms, reducing symptomatic medication use, and improving allergyrelated quality of life. The evidence is strong that AIT achieves these goals and can alter the course of the disease, with benefits persisting in many patients for several years after treatment discontinuation.

The global allergy immunotherapy market is primarily driven by the rising prevalence of allergic conditions, such as allergic rhinitis, asthma, and food allergies, which affect hundreds of millions of individuals worldwide. Growing awareness about long-term treatment options and the effectiveness of immunotherapy in providing sustained symptom relief is increasing its adoption. Additionally, advancements in diagnostic techniques, improved formulations such as sublingual tablets, and support from regulatory authorities have facilitated market growth. The increasing demand for personalized medicine and a shift toward disease-modifying therapies are further propelling the market forward.

Despite its therapeutic potential, the allergy immunotherapy market faces several challenges. The long treatment duration-often lasting three to five years-can lead to poor patient compliance and high dropout rates. High upfront costs and limited reimbursement in some regions restrict accessibility for many patients. Moreover, the requirement for specialized healthcare infrastructure and trained professionals, especially for subcutaneous immunotherapy, limits adoption in low-resource settings. Safety concerns, including the risk of systemic allergic reactions, also hinder broader acceptance, particularly among pediatric and elderly populations. These barriers collectively slow market penetration and limit the therapy's full potential.

This report aims to provide a comprehensive presentation of the global market for Allergy Immunotherapy, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Allergy Immunotherapy by region & country, by Type, and by Application.

The Allergy Immunotherapy market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Allergy Immunotherapy.

Market Segmentation

By Company

  • ALK-Abello
  • Stallergenes Greer
  • Merck
  • Allergy Therapeutics
  • HAL
  • Holister Stier
  • Leti
  • WOLW Pharma

Segment by Type

  • Subcutaneous Immunotherapy
  • Sublingual Immunotherapy

Segment by Application

  • Allergic Rhinitis
  • Allergic Asthma
  • Others

By Region

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Netherlands
    • Nordic Countries
    • Rest of Europe
  • Latin America
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE
    • Rest of MEA

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Allergy Immunotherapy manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Sales, revenue of Allergy Immunotherapy in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Sales, revenue of Allergy Immunotherapy in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

Table of Contents

1 Market Overview

  • 1.1 Allergy Immunotherapy Product Introduction
  • 1.2 Global Allergy Immunotherapy Market Size Forecast
    • 1.2.1 Global Allergy Immunotherapy Sales Value (2020-2031)
    • 1.2.2 Global Allergy Immunotherapy Sales Volume (2020-2031)
    • 1.2.3 Global Allergy Immunotherapy Sales Price (2020-2031)
  • 1.3 Allergy Immunotherapy Market Trends & Drivers
    • 1.3.1 Allergy Immunotherapy Industry Trends
    • 1.3.2 Allergy Immunotherapy Market Drivers & Opportunity
    • 1.3.3 Allergy Immunotherapy Market Challenges
    • 1.3.4 Allergy Immunotherapy Market Restraints
  • 1.4 Assumptions and Limitations
  • 1.5 Study Objectives
  • 1.6 Years Considered

2 Competitive Analysis by Company

  • 2.1 Global Allergy Immunotherapy Players Revenue Ranking (2024)
  • 2.2 Global Allergy Immunotherapy Revenue by Company (2020-2025)
  • 2.3 Global Allergy Immunotherapy Players Sales Volume Ranking (2024)
  • 2.4 Global Allergy Immunotherapy Sales Volume by Company Players (2020-2025)
  • 2.5 Global Allergy Immunotherapy Average Price by Company (2020-2025)
  • 2.6 Key Manufacturers Allergy Immunotherapy Manufacturing Base and Headquarters
  • 2.7 Key Manufacturers Allergy Immunotherapy Product Offered
  • 2.8 Key Manufacturers Time to Begin Mass Production of Allergy Immunotherapy
  • 2.9 Allergy Immunotherapy Market Competitive Analysis
    • 2.9.1 Allergy Immunotherapy Market Concentration Rate (2020-2025)
    • 2.9.2 Global 5 and 10 Largest Manufacturers by Allergy Immunotherapy Revenue in 2024
    • 2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Allergy Immunotherapy as of 2024)
  • 2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

  • 3.1 Introduction by Type
    • 3.1.1 Subcutaneous Immunotherapy
    • 3.1.2 Sublingual Immunotherapy
  • 3.2 Global Allergy Immunotherapy Sales Value by Type
    • 3.2.1 Global Allergy Immunotherapy Sales Value by Type (2020 VS 2024 VS 2031)
    • 3.2.2 Global Allergy Immunotherapy Sales Value, by Type (2020-2031)
    • 3.2.3 Global Allergy Immunotherapy Sales Value, by Type (%) (2020-2031)
  • 3.3 Global Allergy Immunotherapy Sales Volume by Type
    • 3.3.1 Global Allergy Immunotherapy Sales Volume by Type (2020 VS 2024 VS 2031)
    • 3.3.2 Global Allergy Immunotherapy Sales Volume, by Type (2020-2031)
    • 3.3.3 Global Allergy Immunotherapy Sales Volume, by Type (%) (2020-2031)
  • 3.4 Global Allergy Immunotherapy Average Price by Type (2020-2031)

4 Segmentation by Application

  • 4.1 Introduction by Application
    • 4.1.1 Allergic Rhinitis
    • 4.1.2 Allergic Asthma
    • 4.1.3 Others
  • 4.2 Global Allergy Immunotherapy Sales Value by Application
    • 4.2.1 Global Allergy Immunotherapy Sales Value by Application (2020 VS 2024 VS 2031)
    • 4.2.2 Global Allergy Immunotherapy Sales Value, by Application (2020-2031)
    • 4.2.3 Global Allergy Immunotherapy Sales Value, by Application (%) (2020-2031)
  • 4.3 Global Allergy Immunotherapy Sales Volume by Application
    • 4.3.1 Global Allergy Immunotherapy Sales Volume by Application (2020 VS 2024 VS 2031)
    • 4.3.2 Global Allergy Immunotherapy Sales Volume, by Application (2020-2031)
    • 4.3.3 Global Allergy Immunotherapy Sales Volume, by Application (%) (2020-2031)
  • 4.4 Global Allergy Immunotherapy Average Price by Application (2020-2031)

5 Segmentation by Region

  • 5.1 Global Allergy Immunotherapy Sales Value by Region
    • 5.1.1 Global Allergy Immunotherapy Sales Value by Region: 2020 VS 2024 VS 2031
    • 5.1.2 Global Allergy Immunotherapy Sales Value by Region (2020-2025)
    • 5.1.3 Global Allergy Immunotherapy Sales Value by Region (2026-2031)
    • 5.1.4 Global Allergy Immunotherapy Sales Value by Region (%), (2020-2031)
  • 5.2 Global Allergy Immunotherapy Sales Volume by Region
    • 5.2.1 Global Allergy Immunotherapy Sales Volume by Region: 2020 VS 2024 VS 2031
    • 5.2.2 Global Allergy Immunotherapy Sales Volume by Region (2020-2025)
    • 5.2.3 Global Allergy Immunotherapy Sales Volume by Region (2026-2031)
    • 5.2.4 Global Allergy Immunotherapy Sales Volume by Region (%), (2020-2031)
  • 5.3 Global Allergy Immunotherapy Average Price by Region (2020-2031)
  • 5.4 North America
    • 5.4.1 North America Allergy Immunotherapy Sales Value, 2020-2031
    • 5.4.2 North America Allergy Immunotherapy Sales Value by Country (%), 2024 VS 2031
  • 5.5 Europe
    • 5.5.1 Europe Allergy Immunotherapy Sales Value, 2020-2031
    • 5.5.2 Europe Allergy Immunotherapy Sales Value by Country (%), 2024 VS 2031
  • 5.6 Asia Pacific
    • 5.6.1 Asia Pacific Allergy Immunotherapy Sales Value, 2020-2031
    • 5.6.2 Asia Pacific Allergy Immunotherapy Sales Value by Region (%), 2024 VS 2031
  • 5.7 South America
    • 5.7.1 South America Allergy Immunotherapy Sales Value, 2020-2031
    • 5.7.2 South America Allergy Immunotherapy Sales Value by Country (%), 2024 VS 2031
  • 5.8 Middle East & Africa
    • 5.8.1 Middle East & Africa Allergy Immunotherapy Sales Value, 2020-2031
    • 5.8.2 Middle East & Africa Allergy Immunotherapy Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

  • 6.1 Key Countries/Regions Allergy Immunotherapy Sales Value Growth Trends, 2020 VS 2024 VS 2031
  • 6.2 Key Countries/Regions Allergy Immunotherapy Sales Value and Sales Volume
    • 6.2.1 Key Countries/Regions Allergy Immunotherapy Sales Value, 2020-2031
    • 6.2.2 Key Countries/Regions Allergy Immunotherapy Sales Volume, 2020-2031
  • 6.3 United States
    • 6.3.1 United States Allergy Immunotherapy Sales Value, 2020-2031
    • 6.3.2 United States Allergy Immunotherapy Sales Value by Type (%), 2024 VS 2031
    • 6.3.3 United States Allergy Immunotherapy Sales Value by Application, 2024 VS 2031
  • 6.4 Europe
    • 6.4.1 Europe Allergy Immunotherapy Sales Value, 2020-2031
    • 6.4.2 Europe Allergy Immunotherapy Sales Value by Type (%), 2024 VS 2031
    • 6.4.3 Europe Allergy Immunotherapy Sales Value by Application, 2024 VS 2031
  • 6.5 China
    • 6.5.1 China Allergy Immunotherapy Sales Value, 2020-2031
    • 6.5.2 China Allergy Immunotherapy Sales Value by Type (%), 2024 VS 2031
    • 6.5.3 China Allergy Immunotherapy Sales Value by Application, 2024 VS 2031
  • 6.6 Japan
    • 6.6.1 Japan Allergy Immunotherapy Sales Value, 2020-2031
    • 6.6.2 Japan Allergy Immunotherapy Sales Value by Type (%), 2024 VS 2031
    • 6.6.3 Japan Allergy Immunotherapy Sales Value by Application, 2024 VS 2031
  • 6.7 South Korea
    • 6.7.1 South Korea Allergy Immunotherapy Sales Value, 2020-2031
    • 6.7.2 South Korea Allergy Immunotherapy Sales Value by Type (%), 2024 VS 2031
    • 6.7.3 South Korea Allergy Immunotherapy Sales Value by Application, 2024 VS 2031
  • 6.8 Southeast Asia
    • 6.8.1 Southeast Asia Allergy Immunotherapy Sales Value, 2020-2031
    • 6.8.2 Southeast Asia Allergy Immunotherapy Sales Value by Type (%), 2024 VS 2031
    • 6.8.3 Southeast Asia Allergy Immunotherapy Sales Value by Application, 2024 VS 2031
  • 6.9 India
    • 6.9.1 India Allergy Immunotherapy Sales Value, 2020-2031
    • 6.9.2 India Allergy Immunotherapy Sales Value by Type (%), 2024 VS 2031
    • 6.9.3 India Allergy Immunotherapy Sales Value by Application, 2024 VS 2031

7 Company Profiles

  • 7.1 ALK-Abello
    • 7.1.1 ALK-Abello Company Information
    • 7.1.2 ALK-Abello Introduction and Business Overview
    • 7.1.3 ALK-Abello Allergy Immunotherapy Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.1.4 ALK-Abello Allergy Immunotherapy Product Offerings
    • 7.1.5 ALK-Abello Recent Development
  • 7.2 Stallergenes Greer
    • 7.2.1 Stallergenes Greer Company Information
    • 7.2.2 Stallergenes Greer Introduction and Business Overview
    • 7.2.3 Stallergenes Greer Allergy Immunotherapy Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.2.4 Stallergenes Greer Allergy Immunotherapy Product Offerings
    • 7.2.5 Stallergenes Greer Recent Development
  • 7.3 Merck
    • 7.3.1 Merck Company Information
    • 7.3.2 Merck Introduction and Business Overview
    • 7.3.3 Merck Allergy Immunotherapy Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.3.4 Merck Allergy Immunotherapy Product Offerings
    • 7.3.5 Merck Recent Development
  • 7.4 Allergy Therapeutics
    • 7.4.1 Allergy Therapeutics Company Information
    • 7.4.2 Allergy Therapeutics Introduction and Business Overview
    • 7.4.3 Allergy Therapeutics Allergy Immunotherapy Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.4.4 Allergy Therapeutics Allergy Immunotherapy Product Offerings
    • 7.4.5 Allergy Therapeutics Recent Development
  • 7.5 HAL
    • 7.5.1 HAL Company Information
    • 7.5.2 HAL Introduction and Business Overview
    • 7.5.3 HAL Allergy Immunotherapy Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.5.4 HAL Allergy Immunotherapy Product Offerings
    • 7.5.5 HAL Recent Development
  • 7.6 Holister Stier
    • 7.6.1 Holister Stier Company Information
    • 7.6.2 Holister Stier Introduction and Business Overview
    • 7.6.3 Holister Stier Allergy Immunotherapy Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.6.4 Holister Stier Allergy Immunotherapy Product Offerings
    • 7.6.5 Holister Stier Recent Development
  • 7.7 Leti
    • 7.7.1 Leti Company Information
    • 7.7.2 Leti Introduction and Business Overview
    • 7.7.3 Leti Allergy Immunotherapy Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.7.4 Leti Allergy Immunotherapy Product Offerings
    • 7.7.5 Leti Recent Development
  • 7.8 WOLW Pharma
    • 7.8.1 WOLW Pharma Company Information
    • 7.8.2 WOLW Pharma Introduction and Business Overview
    • 7.8.3 WOLW Pharma Allergy Immunotherapy Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.8.4 WOLW Pharma Allergy Immunotherapy Product Offerings
    • 7.8.5 WOLW Pharma Recent Development

8 Industry Chain Analysis

  • 8.1 Allergy Immunotherapy Industrial Chain
  • 8.2 Allergy Immunotherapy Upstream Analysis
    • 8.2.1 Key Raw Materials
    • 8.2.2 Raw Materials Key Suppliers
    • 8.2.3 Manufacturing Cost Structure
  • 8.3 Midstream Analysis
  • 8.4 Downstream Analysis (Customers Analysis)
  • 8.5 Sales Model and Sales Channels
    • 8.5.1 Allergy Immunotherapy Sales Model
    • 8.5.2 Sales Channel
    • 8.5.3 Allergy Immunotherapy Distributors

9 Research Findings and Conclusion

10 Appendix

  • 10.1 Research Methodology
    • 10.1.1 Methodology/Research Approach
      • 10.1.1.1 Research Programs/Design
      • 10.1.1.2 Market Size Estimation
      • 10.1.1.3 Market Breakdown and Data Triangulation
    • 10.1.2 Data Source
      • 10.1.2.1 Secondary Sources
      • 10.1.2.2 Primary Sources
  • 10.2 Author Details
  • 10.3 Disclaimer

List of Tables

  • Table 1. Allergy Immunotherapy Market Trends
  • Table 2. Allergy Immunotherapy Market Drivers & Opportunity
  • Table 3. Allergy Immunotherapy Market Challenges
  • Table 4. Allergy Immunotherapy Market Restraints
  • Table 5. Global Allergy Immunotherapy Revenue by Company (2020-2025) & (US$ Million)
  • Table 6. Global Allergy Immunotherapy Revenue Market Share by Company (2020-2025)
  • Table 7. Global Allergy Immunotherapy Sales Volume by Company (2020-2025) & (K Units)
  • Table 8. Global Allergy Immunotherapy Sales Volume Market Share by Company (2020-2025)
  • Table 9. Global Market Allergy Immunotherapy Price by Company (2020-2025) & (US$/Unit)
  • Table 10. Key Manufacturers Allergy Immunotherapy Manufacturing Base and Headquarters
  • Table 11. Key Manufacturers Allergy Immunotherapy Product Type
  • Table 12. Key Manufacturers Time to Begin Mass Production of Allergy Immunotherapy
  • Table 13. Global Allergy Immunotherapy Manufacturers Market Concentration Ratio (CR5 and HHI)
  • Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Allergy Immunotherapy as of 2024)
  • Table 15. Mergers & Acquisitions, Expansion Plans
  • Table 16. Global Allergy Immunotherapy Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
  • Table 17. Global Allergy Immunotherapy Sales Value by Type (2020-2025) & (US$ Million)
  • Table 18. Global Allergy Immunotherapy Sales Value by Type (2026-2031) & (US$ Million)
  • Table 19. Global Allergy Immunotherapy Sales Market Share in Value by Type (2020-2025)
  • Table 20. Global Allergy Immunotherapy Sales Market Share in Value by Type (2026-2031)
  • Table 21. Global Allergy Immunotherapy Sales Volume by Type: 2020 VS 2024 VS 2031 (K Units)
  • Table 22. Global Allergy Immunotherapy Sales Volume by Type (2020-2025) & (K Units)
  • Table 23. Global Allergy Immunotherapy Sales Volume by Type (2026-2031) & (K Units)
  • Table 24. Global Allergy Immunotherapy Sales Market Share in Volume by Type (2020-2025)
  • Table 25. Global Allergy Immunotherapy Sales Market Share in Volume by Type (2026-2031)
  • Table 26. Global Allergy Immunotherapy Price by Type (2020-2025) & (US$/Unit)
  • Table 27. Global Allergy Immunotherapy Price by Type (2026-2031) & (US$/Unit)
  • Table 28. Global Allergy Immunotherapy Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
  • Table 29. Global Allergy Immunotherapy Sales Value by Application (2020-2025) & (US$ Million)
  • Table 30. Global Allergy Immunotherapy Sales Value by Application (2026-2031) & (US$ Million)
  • Table 31. Global Allergy Immunotherapy Sales Market Share in Value by Application (2020-2025)
  • Table 32. Global Allergy Immunotherapy Sales Market Share in Value by Application (2026-2031)
  • Table 33. Global Allergy Immunotherapy Sales Volume by Application: 2020 VS 2024 VS 2031 (K Units)
  • Table 34. Global Allergy Immunotherapy Sales Volume by Application (2020-2025) & (K Units)
  • Table 35. Global Allergy Immunotherapy Sales Volume by Application (2026-2031) & (K Units)
  • Table 36. Global Allergy Immunotherapy Sales Market Share in Volume by Application (2020-2025)
  • Table 37. Global Allergy Immunotherapy Sales Market Share in Volume by Application (2026-2031)
  • Table 38. Global Allergy Immunotherapy Price by Application (2020-2025) & (US$/Unit)
  • Table 39. Global Allergy Immunotherapy Price by Application (2026-2031) & (US$/Unit)
  • Table 40. Global Allergy Immunotherapy Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
  • Table 41. Global Allergy Immunotherapy Sales Value by Region (2020-2025) & (US$ Million)
  • Table 42. Global Allergy Immunotherapy Sales Value by Region (2026-2031) & (US$ Million)
  • Table 43. Global Allergy Immunotherapy Sales Value by Region (2020-2025) & (%)
  • Table 44. Global Allergy Immunotherapy Sales Value by Region (2026-2031) & (%)
  • Table 45. Global Allergy Immunotherapy Sales Volume by Region (K Units): 2020 VS 2024 VS 2031
  • Table 46. Global Allergy Immunotherapy Sales Volume by Region (2020-2025) & (K Units)
  • Table 47. Global Allergy Immunotherapy Sales Volume by Region (2026-2031) & (K Units)
  • Table 48. Global Allergy Immunotherapy Sales Volume by Region (2020-2025) & (%)
  • Table 49. Global Allergy Immunotherapy Sales Volume by Region (2026-2031) & (%)
  • Table 50. Global Allergy Immunotherapy Average Price by Region (2020-2025) & (US$/Unit)
  • Table 51. Global Allergy Immunotherapy Average Price by Region (2026-2031) & (US$/Unit)
  • Table 52. Key Countries/Regions Allergy Immunotherapy Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
  • Table 53. Key Countries/Regions Allergy Immunotherapy Sales Value, (2020-2025) & (US$ Million)
  • Table 54. Key Countries/Regions Allergy Immunotherapy Sales Value, (2026-2031) & (US$ Million)
  • Table 55. Key Countries/Regions Allergy Immunotherapy Sales Volume, (2020-2025) & (K Units)
  • Table 56. Key Countries/Regions Allergy Immunotherapy Sales Volume, (2026-2031) & (K Units)
  • Table 57. ALK-Abello Company Information
  • Table 58. ALK-Abello Introduction and Business Overview
  • Table 59. ALK-Abello Allergy Immunotherapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 60. ALK-Abello Allergy Immunotherapy Product Offerings
  • Table 61. ALK-Abello Recent Development
  • Table 62. Stallergenes Greer Company Information
  • Table 63. Stallergenes Greer Introduction and Business Overview
  • Table 64. Stallergenes Greer Allergy Immunotherapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 65. Stallergenes Greer Allergy Immunotherapy Product Offerings
  • Table 66. Stallergenes Greer Recent Development
  • Table 67. Merck Company Information
  • Table 68. Merck Introduction and Business Overview
  • Table 69. Merck Allergy Immunotherapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 70. Merck Allergy Immunotherapy Product Offerings
  • Table 71. Merck Recent Development
  • Table 72. Allergy Therapeutics Company Information
  • Table 73. Allergy Therapeutics Introduction and Business Overview
  • Table 74. Allergy Therapeutics Allergy Immunotherapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 75. Allergy Therapeutics Allergy Immunotherapy Product Offerings
  • Table 76. Allergy Therapeutics Recent Development
  • Table 77. HAL Company Information
  • Table 78. HAL Introduction and Business Overview
  • Table 79. HAL Allergy Immunotherapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 80. HAL Allergy Immunotherapy Product Offerings
  • Table 81. HAL Recent Development
  • Table 82. Holister Stier Company Information
  • Table 83. Holister Stier Introduction and Business Overview
  • Table 84. Holister Stier Allergy Immunotherapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 85. Holister Stier Allergy Immunotherapy Product Offerings
  • Table 86. Holister Stier Recent Development
  • Table 87. Leti Company Information
  • Table 88. Leti Introduction and Business Overview
  • Table 89. Leti Allergy Immunotherapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 90. Leti Allergy Immunotherapy Product Offerings
  • Table 91. Leti Recent Development
  • Table 92. WOLW Pharma Company Information
  • Table 93. WOLW Pharma Introduction and Business Overview
  • Table 94. WOLW Pharma Allergy Immunotherapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 95. WOLW Pharma Allergy Immunotherapy Product Offerings
  • Table 96. WOLW Pharma Recent Development
  • Table 97. Key Raw Materials Lists
  • Table 98. Raw Materials Key Suppliers Lists
  • Table 99. Allergy Immunotherapy Downstream Customers
  • Table 100. Allergy Immunotherapy Distributors List
  • Table 101. Research Programs/Design for This Report
  • Table 102. Key Data Information from Secondary Sources
  • Table 103. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Allergy Immunotherapy Product Picture
  • Figure 2. Global Allergy Immunotherapy Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
  • Figure 3. Global Allergy Immunotherapy Sales Value (2020-2031) & (US$ Million)
  • Figure 4. Global Allergy Immunotherapy Sales Volume (2020-2031) & (K Units)
  • Figure 5. Global Allergy Immunotherapy Sales Price (2020-2031) & (US$/Unit)
  • Figure 6. Allergy Immunotherapy Report Years Considered
  • Figure 7. Global Allergy Immunotherapy Players Revenue Ranking (2024) & (US$ Million)
  • Figure 8. Global Allergy Immunotherapy Players Sales Volume Ranking (2024) & (K Units)
  • Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Allergy Immunotherapy Revenue in 2024
  • Figure 10. Allergy Immunotherapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
  • Figure 11. Subcutaneous Immunotherapy Picture
  • Figure 12. Sublingual Immunotherapy Picture
  • Figure 13. Global Allergy Immunotherapy Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
  • Figure 14. Global Allergy Immunotherapy Sales Value Market Share by Type, 2024 & 2031
  • Figure 15. Global Allergy Immunotherapy Sales Volume by Type (2020 VS 2024 VS 2031) & (K Units)
  • Figure 16. Global Allergy Immunotherapy Sales Volume Market Share by Type, 2024 & 2031
  • Figure 17. Global Allergy Immunotherapy Price by Type (2020-2031) & (US$/Unit)
  • Figure 18. Product Picture of Allergic Rhinitis
  • Figure 19. Product Picture of Allergic Asthma
  • Figure 20. Product Picture of Others
  • Figure 21. Global Allergy Immunotherapy Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
  • Figure 22. Global Allergy Immunotherapy Sales Value Market Share by Application, 2024 & 2031
  • Figure 23. Global Allergy Immunotherapy Sales Volume by Application (2020 VS 2024 VS 2031) & (K Units)
  • Figure 24. Global Allergy Immunotherapy Sales Volume Market Share by Application, 2024 & 2031
  • Figure 25. Global Allergy Immunotherapy Price by Application (2020-2031) & (US$/Unit)
  • Figure 26. North America Allergy Immunotherapy Sales Value (2020-2031) & (US$ Million)
  • Figure 27. North America Allergy Immunotherapy Sales Value by Country (%), 2024 VS 2031
  • Figure 28. Europe Allergy Immunotherapy Sales Value, (2020-2031) & (US$ Million)
  • Figure 29. Europe Allergy Immunotherapy Sales Value by Country (%), 2024 VS 2031
  • Figure 30. Asia Pacific Allergy Immunotherapy Sales Value, (2020-2031) & (US$ Million)
  • Figure 31. Asia Pacific Allergy Immunotherapy Sales Value by Region (%), 2024 VS 2031
  • Figure 32. South America Allergy Immunotherapy Sales Value, (2020-2031) & (US$ Million)
  • Figure 33. South America Allergy Immunotherapy Sales Value by Country (%), 2024 VS 2031
  • Figure 34. Middle East & Africa Allergy Immunotherapy Sales Value, (2020-2031) & (US$ Million)
  • Figure 35. Middle East & Africa Allergy Immunotherapy Sales Value by Country (%), 2024 VS 2031
  • Figure 36. Key Countries/Regions Allergy Immunotherapy Sales Value (%), (2020-2031)
  • Figure 37. Key Countries/Regions Allergy Immunotherapy Sales Volume (%), (2020-2031)
  • Figure 38. United States Allergy Immunotherapy Sales Value, (2020-2031) & (US$ Million)
  • Figure 39. United States Allergy Immunotherapy Sales Value by Type (%), 2024 VS 2031
  • Figure 40. United States Allergy Immunotherapy Sales Value by Application (%), 2024 VS 2031
  • Figure 41. Europe Allergy Immunotherapy Sales Value, (2020-2031) & (US$ Million)
  • Figure 42. Europe Allergy Immunotherapy Sales Value by Type (%), 2024 VS 2031
  • Figure 43. Europe Allergy Immunotherapy Sales Value by Application (%), 2024 VS 2031
  • Figure 44. China Allergy Immunotherapy Sales Value, (2020-2031) & (US$ Million)
  • Figure 45. China Allergy Immunotherapy Sales Value by Type (%), 2024 VS 2031
  • Figure 46. China Allergy Immunotherapy Sales Value by Application (%), 2024 VS 2031
  • Figure 47. Japan Allergy Immunotherapy Sales Value, (2020-2031) & (US$ Million)
  • Figure 48. Japan Allergy Immunotherapy Sales Value by Type (%), 2024 VS 2031
  • Figure 49. Japan Allergy Immunotherapy Sales Value by Application (%), 2024 VS 2031
  • Figure 50. South Korea Allergy Immunotherapy Sales Value, (2020-2031) & (US$ Million)
  • Figure 51. South Korea Allergy Immunotherapy Sales Value by Type (%), 2024 VS 2031
  • Figure 52. South Korea Allergy Immunotherapy Sales Value by Application (%), 2024 VS 2031
  • Figure 53. Southeast Asia Allergy Immunotherapy Sales Value, (2020-2031) & (US$ Million)
  • Figure 54. Southeast Asia Allergy Immunotherapy Sales Value by Type (%), 2024 VS 2031
  • Figure 55. Southeast Asia Allergy Immunotherapy Sales Value by Application (%), 2024 VS 2031
  • Figure 56. India Allergy Immunotherapy Sales Value, (2020-2031) & (US$ Million)
  • Figure 57. India Allergy Immunotherapy Sales Value by Type (%), 2024 VS 2031
  • Figure 58. India Allergy Immunotherapy Sales Value by Application (%), 2024 VS 2031
  • Figure 59. Allergy Immunotherapy Industrial Chain
  • Figure 60. Allergy Immunotherapy Manufacturing Cost Structure
  • Figure 61. Channels of Distribution (Direct Sales, and Distribution)
  • Figure 62. Bottom-up and Top-down Approaches for This Report
  • Figure 63. Data Triangulation
  • Figure 64. Key Executives Interviewed